Chicago Brain Tumor Group is categorized under Primary Care Centers in Chicago, IL and active since 2007.
Chicago Brain Tumor Group was established in 2007, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Primary Care Centers business, which does work in the B2C market, and is classified as a Primary Care Centers, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact George Dohrmann at the company’s single location by writing to 5841 South Maryland Avenue, Chicago, Illinois IL 60637 or by phoning (312) 944-6800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chicago Brain Tumor Group |
| Contact Person: | George Dohrmann |
| Address: | 5841 South Maryland Avenue, Chicago, Illinois 60637 |
| Phone Number: | (312) 944-6800 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Primary Care Centers |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Chicago Brain Tumor Group was started in 2007 to provide professional Primary Care Centers under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact George Dohrmann for inquiries that concern Chicago Brain Tumor Group by calling the company number (312) 944-6800, as your correspondence is most welcome. Additionally, the physical location of the single location of Chicago Brain Tumor Group can be found at the coordinates 41.788778,-87.60488 as well as the street address 5841 South Maryland Avenue in Chicago, Illinois 60637.
For its online presence, you may visit Chicago Brain Tumor Group’s website at and engage with its social media outlets through on Twitter and on Facebook.